Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00424008
Status:
COMPLETED
Last Update Posted:
2024-05-20
First Post:
2007-01-17
Brief Title:
Study of Inhaled GlucocorticosteroidsLong-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids Study P04705AM1
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A 52-Week Efficacy and Safety Non-Inferiority Study of Fluticasone PropionateSalmeterol 25050mcg BID Delivered by Dry Powder Inhaler Diskus Versus Mometasone FuroateFormoterol Fumarate 20010mcg BID Delivered by Pressurized Metered-Dose Inhaler in Persistent Asthmatics Previously Treated With Medium Doses of Inhaled Glucocorticosteroids
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being conducted to demonstrate the non-inferiority between two inhaled glucocorticosteroids and long-acting bronchodilator combination drugs called mometasone furoateformoterol fumarate in a metered-dose inhaler MDI and fluticasone propionatesalmeterol in a dry powder inhaler DPI on lung function Information on the onset of action the overall safety and how the drugs control asthma will also be assessed The study is approximately 1 year in duration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| SCH 418131 | None | None | None |